Disclosures for "Evaluating the Effect of a Bruton’s Tyrosine Kinase Inhibitor in a Murine Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis")
-
Dr. Gruber has received personal compensation for serving as an employee of Sanofi. Dr. Gruber has received stock or an ownership interest from Sanofi.
-
Dr. Blazier has received personal compensation for serving as an employee of Sanofi.
-
Lan Lee has nothing to disclose.
-
Dr. Ryan has nothing to disclose.
-
Dr. Cheong has received personal compensation for serving as an employee of Sanofi.
-
Ms. Havari has received personal compensation for serving as an employee of sanofi.
-
Timothy J. Turner has received personal compensation for serving as an employee of Sanofi. Timothy J. Turner has received stock or an ownership interest from Sanofi. Timothy J. Turner has received intellectual property interests from a discovery or technology relating to health care.
-
Dimitry Ofengeim has received personal compensation for serving as an employee of Sanofi. Dimitry Ofengeim has received stock or an ownership interest from Sanofi. Dimitry Ofengeim has received personal compensation in the range of $500-$4,999 for serving as a Study Section Reveiwer with NIH.